Use of randomised trials to decide when to monitor response to new treatment.

Bell, Katy J.L.; Irwig, Les; Craig, Jonathan C; Macaskill, Petra

Access status:

Open Access

Field	Value	Language
dc.contributor.author	Bell, Katy J.L.
dc.contributor.author	Irwig, Les
dc.contributor.author	Craig, Jonathan C
dc.contributor.author	Macaskill, Petra
dc.date.accessioned	2021-02-24T23:38:43Z
dc.date.available	2021-02-24T23:38:43Z
dc.date.issued	2008	en_AU
dc.identifier.uri	https://hdl.handle.net/2123/24562
dc.description.abstract	Is monitoring initial response to treatment always helpful in clinical management of patients? Bell and colleagues have developed a framework for deciding whether surrogate outcomes should be used to monitor initial response to treatment in chronic disease.	en_AU
dc.publisher	BMJ Publishing Group	en_AU
dc.relation.ispartof	British Medical Journal	en_AU
dc.rights	Copyright All Rights Reserved	en_AU
dc.subject	hypertension	en_AU
dc.subject	health outcomes	en_AU
dc.subject	blood pressure	en_AU
dc.subject	epidemiology	en_AU
dc.subject	statistical	en_AU
dc.subject	chronic disease	en_AU
dc.title	Use of randomised trials to decide when to monitor response to new treatment.	en_AU
dc.type	Article	en_AU
dc.subject.asrc	1102 Cardiorespiratory Medicine and Haematology	en_AU
dc.subject.asrc	1117 Public Health and Health Services	en_AU
dc.identifier.doi	10.1136/bmj.39476.623611.25
dc.relation.nhmrc	402764
dc.rights.other	This article has been accepted for publication in BMJ 2008 following peer review, and the Version of Record can be accessed online at doi:10.1136/bmj.39476.623611.25	en_AU
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Health	en_AU
usyd.citation.volume	336	en_AU
usyd.citation.issue	7640	en_AU
usyd.citation.spage	361	en_AU
usyd.citation.epage	365	en_AU
workflow.metadata.only	No	en_AU